BioRestorative Therapies
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $11 | $303 | $25 | $43 |
Gross Profit | -51 | 294 | 22 | 39 |
EBITDA | -2,985 | -2,603 | -4,755 | -2,639 |
EBIT | -3,038 | -2,656 | -4,807 | -2,690 |
Net Income | -3,038 | -2,656 | -5,339 | -1,636 |
Net Change In Cash | 11 | 303 | 25 | 43 |
Free Cash Flow | -2,901 | -2,693 | -2,815 | -2,360 |
Cash | 602 | 1,555 | 1,228 | 547 |
Basic Shares | 9,116 | 8,740 | 8,357 | 7,763 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $401 | $145 | $119 | $46 |
Gross Profit | 372 | 145 | 119 | 46 |
EBITDA | -11,366 | -14,971 | -18,742 | -26,218 |
EBIT | -11,555 | -15,137 | -18,863 | -26,307 |
Net Income | -8,979 | -10,417 | -13,222 | -44,303 |
Net Change In Cash | 401 | 145 | 119 | 46 |
Free Cash Flow | -8,336 | -6,601 | -6,353 | -3,360 |
Cash | 547 | 884 | 1,713 | 21,026 |
Basic Shares | 7,763 | 4,218 | 3,617 | 1,187 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.33 |
2025-06-30 | -$0.30 |
2025-03-31 | -$0.64 |
2024-12-31 | -$0.37 |
